Search Results - "Allué, Jose A"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Aβ42/Aβ40 ratio in plasma predicts amyloid‐PET status in amnestic‐MCI patients by Pascual‐Lucas, María, Sarasa, Leticia, Molina, Elisabet P., Castillo, Sergio, Pesini, Pedro, Allué, Jose A.

    Published in Alzheimer's & dementia (01-12-2021)
    “…Background We have completed the analytical validation of an antibody‐free, HPLC‐MS/MS method (ABtest‐MS), to quantitate specifically Aβ1‐40 and Aβ1‐42 in…”
    Get full text
    Journal Article
  2. 2

    AB1601 Phase 2 Study of ABvac40, an Anti‐Aβ40 Vaccine: Safety and Immunogenicity of a Cross‐Over Extension by Pascual‐Lucas, María, Lacosta, Ana María, Canudas, Jesús, Montañés, María, Allué, Jose A, Sarasa, Leticia, Molina, Elisabet, Castillo, Sergio, Sarasa, Manuel, Terencio, Jose, Boada, Mercè

    Published in Alzheimer's & dementia (01-12-2023)
    “…Background Amyloid‐β (Aβ) immunotherapy is a promising strategy for treating Alzheimer’s disease (AD). Previous studies suggested that Aβ40 could have an…”
    Get full text
    Journal Article
  3. 3

    AB1601 topline results – Phase 2 study of ABvac40 in patients with amnestic mild cognitive impairment (a‐MCI) or very mild Alzheimer’s Disease (Vm‐AD) by Molina, Elisabet, Castillo, Sergio, Lacosta, Ana M, Allué, Jose A, Fandos, Noelia, Montañés, María, Romero, Judith, Sarasa, Leticia, Boada, Mercè, Sarasa, Manuel

    Published in Alzheimer's & dementia (01-12-2022)
    “…Background Immunotherapy against amyloid β (Aβ) has emerged as a promising treatment option for Alzheimer’s disease (AD). Araclon‐Biotech is developing an…”
    Get full text
    Journal Article
  4. 4

    Contribution of clinical information to the predictive performance of plasma Aβ levels for Aβ PET positivity by Chun, Min Young, Jang, Hyemin, Kim, Hee Jin, Kim, Jun Pyo, Gallacher, John, Allué, Jose A, Sarasa, Leticia, Castillo, Sergio, Pascual‐Lucas, María, Na, Duk L, Seo, Sang Won

    Published in Alzheimer's & dementia (01-12-2023)
    “…Background Early detection of β‐amyloid (Aβ) accumulation, a major biomarker for Alzheimer’s disease (AD), has become important. While Aβ deposition can be…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Detecting amyloid positivity in early Alzheimer disease using plasma biomarkers by Janelidze, Shorena, Palmqvist, Sebastian, Leuzy, Antoine, Stomrud, Erik, Verberk, Inge M.W., Zetterberg, Henrik, Ashton, Nicholas J., Mattsson‐Carlgren, Niklas, Pesini, Pedro, Sarasa, Leticia, Allué, Jose A., Teunissen, Charlotte E., Dage, Jeffrey L., Blennow, Kaj, Hansson, Oskar

    Published in Alzheimer's & dementia (01-12-2021)
    “…Background Recent data suggest that blood biomarkers of amyloid‐β (Aβ) pathology (Aβ42/Aβ40), tau pathology (phosphorylated tau [P‐tau]) and neurodegeneration…”
    Get full text
    Journal Article
  8. 8
  9. 9